Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial. For patients with malignant pleural mesothelioma — which makes up about 90 ...

Doctors at the Mesothelioma Treatment Center at Baylor College of Medicine and Baylor St. Luke’s Medical Center are now offering mesothelioma patients a new FDA-approved device as part of their ...

WASHINGTON – People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the ...

Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural ...

NET of the lung: The experience of the Italian registry. Clinical features in surgically treated patients with small cell lung cancer: Risk of brain metastasis and possible role of prophylactic ...

A novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients who have few treatment options, according to new research. Transarterial ...

John Comerford, senior partner of Lipsitz, Ponterio & Comerford says when people come to see them with mesothelioma, they have to do a little type of investigation to determine how they were exposed ...

Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the pleura. A well defined causal relationship with asbestos exposure, and an overwhelming media interest in the use ...

Asbestos exposure has posed a serious health threat to American Veterans for many decades. Asbestos exposure was common ...

Receiving a mesothelioma diagnosis overwhelms the individual with health problems and Nagging questions that follow. Most ...